Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristics.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Clinical Oncology

• Publication date

  2011-10-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2010.32.6462PMID 21911717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immediate Risk of Suicide and Cardiovascular Death After a Prostate Cancer Diagnosis: Cohort Study in the United States

  2011cited by this paper
• Influence of Isolated Tumor Cells in Sentinel Nodes on Outcome in Small, Node-Negative (pT1N0M0) Breast Cancer

  2010cited by this paper
• Influence of Isolated Tumor Cells in Sentinel Nodes on Outcome in Small, Node-Negative (pT1N0M0) Breast Cancer: Leidenius MHK, Vironen JH, Heikkilä PS, et al (Helsinki Univ Central Hosp, Finland) Ann Surg Oncol 17:254-262, 2010§

  2010cited by this paper
• Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.

  2010cited by this paper
• Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States.

  2010cited by this paper
• Effect of Baseline Breast Density on Breast Cancer Incidence, Stage, Mortality, and Screening Parameters: 25-Year Follow-up of a Swedish Mammographic Screening

  2010cited by this paper
• Misclassification of breast cancer as cause of death in a service screening area

  2009cited by this paper
• Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study

  2009cited by this paper
• How cancer at the primary site and in the lymph nodes contributes to the risk of cancer death

  2009cited by this paper
• Further Development of Flexible Parametric Models for Survival Analysis

  2009cited by this paper
• Micrometastases or isolated tumor cells and the outcome of breast cancer.

  2009cited by this paper
• Improvements in breast cancer survival over time, related to adjuvant treatment and node status.

  2009cited by this paper
• Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer

  2009cited by this paper
• Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment

  2009cited by this paper
• Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease.

  2009cited by this paper
• Patient and tumor characteristics associated with increased mortality in young women (≤40 years) with breast cancer

  2009cited by this paper
• Why cancer at the primary site and in the lymph nodes contributes to the risk of cancer death

  2009cited by this paper
• Population-based study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival.

  2008cited by this paper
• Competing Causes of Death for Women With Breast Cancer and Change Over Time From 1975 to 2003

  2008cited by this paper
• Organised mammography screening reduces breast cancer mortality: A cohort study from Finland

  2008cited by this paper
• Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients

  2007cited by this paper
• A Comprehensive Review of Breast Cancer in Young Women

  2006cited by this paper
• Effects of young age at presentation on survival in breast cancer

  2006cited by this paper
• Hormone receptor status and survival in a population‐based cohort of patients with breast carcinoma

  2005cited by this paper
• Monitoring the decrease in breast cancer mortality in Europe

  2005cited by this paper
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

  2005cited by this paper
• Time-dependence of hazard ratios for prognostic factors in primary breast cancer

  2004cited by this paper
• Time‐dependent effects on survival in breast carcinoma

  2004cited by this paper
• Probabilities of death from breast cancer and other causes among female breast cancer patients.

  2004cited by this paper
• Do young breast cancer patients have worse outcomes?

  2003cited by this paper
• Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects

  2002cited by this paper
• Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer

  2002cited by this paper
• Excess mortality from breast cancer 20 years after diagnosis when life expectancy is normal

  2001cited by this paper
• Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.

  2001cited by this paper
• Stage 0 to stage III breast cancer in young women.

  2000cited by this paper
• Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics.

  2000cited by this paper
• Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

  1999cited by this paper
• Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee.

  1995cited by this paper
• Survival patterns among younger women with breast cancer: the effects of age, race, stage, and treatment.

  1994cited by this paper
• Age as prognostic factor in premenopausal breast carcinoma.

  1993cited by this paper
• Verification of the cause of death in the trial of early detection of breast cancer. UK Trial of Early Detection of Breast Cancer Group. Trial Co-ordinating Centre.

  1991cited by this paper
• The relation between survival and age at diagnosis in breast cancer.

  1986cited by this paper

• Integrative transcriptomic and structural modeling reveal CASP1, TLR3, PYCARD, and CD274 as immune-modulatory drivers in breast cancer.

  2026cites this paper
• Management of Breast Cancer in a Resource-Limited Semi-Urban Setting: A Series of 155 Cases Treated in Garoua, Cameroon

  2025cites this paper
• Very Low Internal Echoes With Enhanced Posterior Echoes Suggest the Aggressive Nature of Expanding Ovoid Breast Cancers: A Case Report

  2025cites this paper
• Coronary artery calcium and cardiovascular risk factors analysis after radiotherapy for breast cancer (the CLARIFIER: a gender-based preventive medicine study)

  2025cites this paper
• Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study.

  2025cites this paper
• Adjuvant therapy guided by molecular classification in endometrial cancer: survival benefit and safety profile.

  2025cites this paper
• The mechanisms of action and targeting potential of vasculogenic mimicry in breast cancer metastasis

  2025cites this paper
• Association between thoracic adiposity and survival in non-metastatic breast cancer

  2025cites this paper
• Causes of death in patients with malignant adrenal tumours: a population-based analysis

  2025cites this paper
• Causal Pathways Between Breast Cancer and Cardiovascular Disease Through Mediator Factors: A Two-Step Mendelian Randomization Analysis

  2024cites this paper
• Multicenter Study on Breast Cancer in the Geriatric Population: Insights for Effective Treatment Strategies.

  2024cites this paper
• Association of Breast Cancer Subtypes and Clinicopathological Factors with Axillary Lymph Node Positivity Amongst Women with Breast Cancer in Rajasthan: An Observational Analytical Study

  2024cites this paper
• Thirty-day hospital readmission in females with acute heart failure and breast cancer: A retrospective cohort study from national readmission database

  2024cites this paper
• Familial adversity: association with discontinuation of adjuvant hormone therapy and breast cancer prognosis

  2024influential citation
• Baseline breast tissue characteristics determine the effect of tamoxifen on mammographic density change

  2024cites this paper
• Comparing the effects of various β-blockers on cardiovascular mortality in breast cancer patients

  2024cites this paper
• Competing risks models with two time scales

  2024cites this paper
• Select gene mutations associated with survival outcomes in ER‐positive ERBB2‐negative early‐stage invasive breast cancer: A single‐institutional tissue bank study

  2024cites this paper
• Prognostic Factors Associated with Breast Cancer-Specific Survival from 1995 to 2022: A Systematic Review and Meta-Analysis of 1,386,663 Cases from 30 Countries

  2024cites this paper
• Loneliness and Mortality Risk Among Cancer Survivors in the United States: A Retrospective, Longitudinal Study.

  2024cites this paper
• Analysis of Breast Cancer Family History, Estrogen Receptor Status, and Breast Cancer Outcomes in Sweden

  2023cites this paper
• Concomitant Discontinuation of Cardiovascular Therapy and Adjuvant Hormone Therapy Among Patients With Breast Cancer

  2023cites this paper
• The influence of anatomic stage and receptor status on first recurrence for breast cancer within 5 years (AFT‐01)

  2023cites this paper
• Long-term risks of cardiovascular death in a population-based cohort of 1,141,675 older patients with cancer.

  2023cites this paper
• Cause of Death among Long-Term Cancer Survivors: The NANDE Study

  2023cites this paper
• Cardiovascular outcomes in breast cancer survivors: a systematic review and meta-analysis.

  2023cites this paper
• Research on the Effects of Chemotherapy on Survival Outcomes for Older Patients with Primary Triple-Negative Breast Cancer after Surgery: A Propensity Score Matching and Competing Risk Analysis of the SEER Database

  2023cites this paper
• Causes of death in women with breast cancer: a risks and rates study on a population-based cohort

  2023cites this paper
• Age-Dependent Causes of Death among Patients with Breast Cancer Based on Osaka Cancer Registry and Vital Statistics in Japan

  2023cites this paper
• Real-world outcomes for Chinese breast cancer patients with tumor location of central and nipple portion

  2022cites this paper
• ROLE OF WT1 AS A PROGNOSTIC MARKER IN BREAST CARCINOMA”

  2022cites this paper
• Risk of heart disease following treatment for breast cancer – results from a population-based cohort study

  2022cites this paper
• Late Breast Cancer Survivorship: Side Effects and Care Recommendations.

  2022cites this paper
• Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study

  2022cites this paper
• In vitro study of the antihypertensive, antioxidant and antiproliferative activities of peptides obtained from two varieties of Phaseolus coccineus L

  2022cites this paper
• A Concomitant Cancer Diagnosis Is Associated With Poor Cardiovascular Outcomes Among Acute Myocardial Infarction Patients

  2022cites this paper
• Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain

  2022cites this paper
• Change in effectiveness of mammography screening with decreasing breast cancer mortality: a population-based study

  2022cites this paper
• Prediction of Cardiac Toxicity by Measurement of Coronary Artery Calcium Scoring Method Using Chest Computed Tomography in Early Breast Cancer Patients Treated with Trastuzumab

  2022cites this paper
• Follow-up and Cancer Survivorship.

  2022cites this paper
• Breast Cancer Subtypes in Northern Thailand and Barriers to satisfactory survival outcomes

  2022cites this paper
• Adjuvant Hormone Therapy-Related Hot Flashes Predict Treatment Discontinuation and Worse Breast Cancer Prognosis.

  2022cites this paper
• Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer

  2022cites this paper
• High mRNA Expression Levels of Heat Shock Protein Family B Member 2 (HSPB2) Are Associated with Breast Cancer Patients’ Relapse and Poor Survival

  2022cites this paper
• Clustering Molecular Subtypes in Breast Cancer, Immunohistochemical Parameters and Risk of Axillary Nodal Involvement

  2022cites this paper
• Prognostic Significance of HALP Score in Early Stage Triple-Negative Breast Cancer

  2022cites this paper
• Lack of Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Early Breast Cancer

  2022cites this paper
• Long-Term Survival and Causes of Death After Diagnoses of Common Cancers in 3 Cohorts of US Health Professionals

  2022cites this paper
• The effect of chemotherapy on survival in oldest old patients with nonmetastatic triple negative breast cancer: A populationbased observational study

  2022influential citation
• Racial and ethnic disparities in mortality among breast cancer survivors after a second malignancy.

  2022cites this paper
• Comorbidities and the risk of cardiovascular disease mortality among racially diverse patients with breast cancer

  2021cites this paper
• Nomograms for Predicting Axillary Lymph Node Status Reconciled With Preoperative Breast Ultrasound Images

  2021cites this paper
• Risk of heart disease following breast cancer: results from a population-based cohort study

  2021cites this paper
• Cause-specific mortality among patients with different molecular subtypes of T1-2N0M0 breast cancer

  2021cites this paper
• Staging computerized tomography before delayed breast reconstruction could alter the management plan.

  2021cites this paper
• Evaluating the monogenic contribution and genotype–phenotype correlation in patients with isolated thoracic aortic aneurysm

  2021cites this paper
• Development and Validation of a Risk Score Model for Predicting the Cardiovascular Outcomes After Breast Cancer Therapy: The CHEMO‐RADIAT Score

  2021cites this paper
• A Clinicogenetic Prognostic Classifier for Prediction of Recurrence and Survival in Asian Breast Cancer Patients

  2021cites this paper
• Evidence-based prediction and prevention of cardiovascular morbidity in adults treated for cancer

  2021cites this paper
• Left Breast Radiotherapy With Multi Fields Hybrid Intensity Modulated Radiotherapy (IMRT) Versus Volumetric Modulated Arc Therapy (VMAT): Balance Between Left Anterior Descending Artery Sparing and Secondary Cancer Induction Risk

  2021cites this paper
• Lymph node metastases in breast cancer: Investigating associations with tumor characteristics, molecular subtypes and polygenic risk score using a continuous growth model

  2021cites this paper
• Prevalence and prognosis of molecular phenotypes in breast cancer patients by age: a population-based retrospective cohort study in western Algeria

  2021cites this paper
• Survival Outcomes Among Patients with Metastatic Breast Cancer: Review of 47,000 Patients

  2021influential citation
• Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer

  2020cites this paper
• Effects of housing value and medical subsidy on treatment and outcomes of breast cancer patients in Singapore: A retrospective cohort study

  2020cites this paper
• Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study

  2020cites this paper
• Predictors of new-onset heart failure and overall survival in metastatic breast cancer patients treated with liposomal doxorubicin

  2020cites this paper
• Impact of Hormone Receptor Status on the Behaviour of HER2+ Breast Cancer

  2020cites this paper
• Screening of germline mutations in young Rwandan patients with breast cancers

  2020cites this paper
• Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients– the BReast cancer EXercise InTervention (BREXIT) trial protocol

  2020cites this paper
• Prognostic significance of incidental suspected transthyretin amyloidosis on routine bone scintigraphy

  2020cites this paper
• Association of triple positivity with prognostic parameters and overall survival in a population-based study of 6,122 HER2-positive breast cancer patients: analysis of real-world clinical practice based on a research database.

  2020cites this paper
• Circuit resistance training and cardiovascular health in breast cancer survivors.

  2020cites this paper
• Profile of Breast Cancer Patients Presenting At a Tertiary Care Centre in an Indian Himalayan State

  2020cites this paper
• All-cause and cardiovascular disease mortality among breast cancer survivors in CLUE II, a long-standing community-based cohort.

  2020cites this paper
• Detection of Lymph Node Metastases by Ultra-pH-Sensitive Polymeric Nanoparticles

  2020cites this paper
• Intensity of Care, Expenditure, and Place of Death in French Women in the Year Before Their Death From Breast Cancer: A Population-Based Study

  2020cites this paper
• Bioinformatics analysis of prognosis-related long non-coding RNAs in invasive breast carcinoma

  2020cites this paper
• Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns

  2020cites this paper
• Cardiovascular mortality and morbidity burden in successive and age pre-stratified case–control cohorts of breast cancer women. A population-based study

  2020cites this paper
• Outcome and Presentation of Heart Failure in Breast Cancer Patients; Findings from a Swedish register-based study.

  2019cites this paper
• Breast Cancer Survival Defined by Biological Receptor and Menopausal Status in Vietnamese Women

  2019cites this paper
• Bragatston study protocol: a multicentre cohort study on automated quantification of cardiovascular calcifications on radiotherapy planning CT scans for cardiovascular risk prediction in patients with breast cancer

  2019influential citation
• Risk of breast cancer based on thermal tomography characteristics

  2019cites this paper
• Breast Cancer in Women Aged 80 Years or Older: An Analysis of Treatment Patterns and Disease Outcomes.

  2019cites this paper
• Persistent Impairment in Cardiopulmonary Fitness following Breast Cancer Chemotherapy.

  2019cites this paper
• Visceral Fat Volume From Standard Preoperative CT is an Independent Predictor of Short-term Survival in Patients Undergoing Surgery for Metastatic Spine Disease

  2019cites this paper
• Predicting breast cancer metastasis by using serum biomarkers and clinicopathological data with machine learning technologies

  2019cites this paper
• Therapeutic significance of hormone receptor positivity in patients with HER-2 positive breast cancer.

  2019cites this paper
• Causes of death after breast cancer diagnosis: A US population‐based analysis

  2019cites this paper
• Survival in breast cancer patients with spine metastases: Prognostic assessment involving molecular markers.

  2019cites this paper
• Differences in clinicopathologic features and subtype distribution of invasive breast cancer between women older and younger than 40 years

  2019cites this paper
• Trends in the risk of cardiovascular disease in women with breast cancer in a Dutch nationwide cohort study

  2019influential citation
• Clinical characteristics and prognostic analysis of ipsilateral supraclavicular lymph node metastases in breast cancer patients: a retrospective study.

  2019cites this paper
• Impact of radiotherapy on cardiovascular health of women with breast cancer

  2019cites this paper
• Cause-specific mortality after a breast cancer diagnosis: a cohort study of 10,195 women in Girona and Tarragona

  2019cites this paper
• Capturing simple and complex time-dependent effects using flexible parametric survival models: A simulation study

  2019cites this paper
• A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases

  2019cites this paper
• Cytosolic Phospholipase A2 Alpha Regulates TLR Signaling and Migration in Metastatic 4T1 Cells

  2019cites this paper
• Cardiorespiratory fitness predicts cardiovascular health in breast cancer survivors, independent of body composition, age and time post-treatment completion

  2019cites this paper